Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$428,288 | -$161,260 | -$1,914,918 | $416,509 |
| Dep. & Amort. | $258,426 | $226,233 | $338,773 | $278,965 |
| Deferred Tax | $0 | $0 | $134,451 | $412,698 |
| Stock-Based Comp. | $418,020 | $89,084 | $89,666 | $59,350 |
| Change in WC | -$13,519 | $111,103 | -$224,117 | -$472,048 |
| Other Non-Cash | $9,248 | -$65,673 | $1,622,638 | -$30,181 |
| Operating Cash Flow | $243,887 | $199,487 | $46,493 | $665,293 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$70,705 | -$125,346 | -$402,459 | -$601,017 |
| Net Acquisitions | $35,000 | $14,925 | $88,448 | -$153,377 |
| Inv. Purchases | -$9,118,511 | -$10,091,380 | -$16,163,360 | -$20,041,950 |
| Inv. Sales/Matur. | $9,645,681 | $10,468,006 | $15,451,028 | $20,193,103 |
| Other Inv. Act. | $266,772 | -$96,328 | -$634,778 | $265,672 |
| Investing Cash Flow | $758,237 | $169,877 | -$1,661,121 | -$337,569 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$291,384 | -$31,382 | $164,894 | $293,643 |
| Stock Issued | $0 | $0 | $0 | $2,737 |
| Stock Repurch. | -$20,298 | -$33,811 | $0 | -$206,407 |
| Dividends Paid | -$177,080 | -$298,560 | -$1,315,530 | -$122,889 |
| Other Fin. Act. | -$769,645 | -$55,808 | $911,702 | $783,576 |
| Financing Cash Flow | -$1,258,407 | -$419,561 | -$238,934 | $750,660 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$256,283 | -$50,197 | -$1,853,562 | $1,078,384 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,778,666 | $3,828,863 | $5,682,425 | $4,604,041 |
| End Cash | $3,522,383 | $3,778,666 | $3,828,863 | $5,682,425 |
| Free Cash Flow | $57,512 | -$95,931 | -$355,966 | $64,276 |